Kura Oncology (KURA)
5.89 x 20 5.90 x 153
Post-market by (Cboe BZX)
5.90 +0.15 (+2.61%) 04/17/25 [NASDAQ]
5.89 x 20 5.90 x 153
Post-market 5.90 unch (unch) 16:25 ET
for Thu, Apr 17th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -173,983 | -152,631 | -135,840 | -130,466 | -89,625 |
| Depreciation Amortization | -12,293 | -8,571 | 2,369 | 4,949 | 604 |
| Other Working Capital | 286,173 | 7,819 | -2,982 | -3,224 | 6,384 |
| Other Operating Activity | 34,420 | 28,559 | 26,391 | 24,190 | 12,807 |
| Operating Cash Flow | $134,317 | $-124,824 | $-110,062 | $-104,551 | $-69,830 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -101,118 | 15,725 | 33,253 | -125,688 | -97,765 |
| PPE Investments | -472 | -168 | -626 | -1,147 | -2,171 |
| Investing Cash Flow | $-101,590 | $15,557 | $32,627 | $-126,835 | $-99,936 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 10,000 | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | -7,250 | -250 |
| Common Stock Issued | 154,417 | 94,783 | 29,140 | 4,426 | 469,584 |
| Other Financing Activity | 0 | 0 | -575 | -611 | 0 |
| Financing Cash Flow | $154,417 | $94,783 | $38,565 | $-3,435 | $469,334 |
| Beginning Cash Position | 37,318 | 51,802 | 90,672 | 325,493 | 26,135 |
| End Cash Position | 224,462 | 37,318 | 51,802 | 90,672 | 325,703 |
| Net Cash Flow | $187,144 | $-14,484 | $-38,870 | $-234,821 | $299,568 |
| Free Cash Flow | |||||
| Operating Cash Flow | 134,317 | -124,824 | -110,062 | -104,551 | -69,830 |
| Capital Expenditure | -472 | -168 | -626 | -1,147 | -2,171 |
| Free Cash Flow | 133,845 | -124,992 | -110,688 | -105,698 | -72,001 |